In the current study, we investigated loss of miR-mediated post-transcriptional regulation of DNMT3b in primary invasive breast cancers as a molecular mechanism governing the overexpression of DNMT3b that drives aberrant DNA hypermethylation in basal-like breast cancer. This evidence concerns the gene DNMT3B and breast carcinoma.